Essential elements of the capsid protein for self-assembly into empty virus-like particles of hepatitis E virus.
about
Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor bindingLessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteinsBiological and immunological characteristics of hepatitis E virus-like particles based on the crystal structureStructural Basis for Broad Detection of Genogroup II Noroviruses by a Monoclonal Antibody That Binds to a Site Occluded in the Viral ParticleMolecular Biology and Infection of Hepatitis E VirusEpidemiology of Hepatitis E in Pregnant Women and Children in Iran: A General OverviewChemically activatable viral capsid functionalized for cancer targetingAdvances in hepatitis E - I: virology, pathogenesis and diagnosis.Mutations within potential glycosylation sites in the capsid protein of hepatitis E virus prevent the formation of infectious virus particles.A Comprehensive Study of Neutralizing Antigenic Sites on the Hepatitis E Virus (HEV) Capsid by Constructing, Clustering, and Characterizing a Tool Box.Hepatitis E virus: animal reservoirs and zoonotic riskSelf-assembly of virus-like particles of porcine circovirus type 2 capsid protein expressed from Escherichia coli.Subviral particle as vaccine and vaccine platform.Molecular virology of hepatitis E virus.Structure of hepatitis E virion-sized particle reveals an RNA-dependent viral assembly pathwayMolecular biology and replication of hepatitis E virus.Spatial configuration of hepatitis E virus antigenic domain.The Hepatitis E virus intraviral interactomeChanges in the cellular proteins of A549 infected with hepatitis E virus by proteomics analysisHepatitis E virus ORF2 protein over-expressed by baculovirus in hepatoma cells, efficiently encapsidates and transmits the viral RNA to naïve cells.Extended Microbiological Characterization of Göttingen Minipigs in the Context of Xenotransplantation: Detection and Vertical Transmission of Hepatitis E Virus.Characterization of self-assembled virus-like particles of rat hepatitis E virus generated by recombinant baculoviruses.Latent infection of a new alphanodavirus in an insect cell line.Cytokine Profiles and Cell Proliferation Responses to Truncated ORF2 Protein in Iranian Patients Recovered from Hepatitis E Infection.Assessment of the cross-protective capability of recombinant capsid proteins derived from pig, rat, and avian hepatitis E viruses (HEV) against challenge with a genotype 3 HEV in pigs.Design, Construction and Cloning of Truncated ORF2 and tPAsp-PADRE-Truncated ORF2 Gene Cassette From Hepatitis E Virus in the pVAX1 Expression Vector.Production of hepatitis E virus-like particles presenting multiple foreign epitopes by co-infection of recombinant baculovirusesCrystallization and preliminary X-ray diffraction analysis of recombinant hepatitis E virus-like particle.The hepatitis E virus capsid C-terminal region is essential for the viral life cycle: implication for viral genome encapsidation and particle stabilizationAntigenic determinants of hepatitis E virus and vaccine-induced immunogenicity and efficacy.Serological immunoassay for detection of hepatitis E virus on the basis of genotype 3 open reading frame 2 recombinant proteins produced in Trichoplusia ni larvae.Designing, Construction and Expression of a Recombinant Fusion Protein Comprising the Hepatitis E Virus ORF2 and Rotavirus NSP4 in the Baculovirus Expression System.Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design.Virus assembly, allostery and antiviralsHepatitis E virus: neutralizing sites, diagnosis, and protective immunity.Expression and characterization of hepatitis E virus-like particles and non-virus-like particles from insect cells.Different applications of virus-like particles in biology and medicine: Vaccination and delivery systems.Asialoglycoprotein receptor facilitates infection of PLC/PRF/5 cells by HEV through interaction with ORF2.Establishment of hepatitis E virus infection-permissive and -non-permissive human hepatoma PLC/PRF/5 subclones.Surface modulatable nanocapsids for targeting and tracking toward nanotheranostic delivery.
P2860
Q24655874-BF662AFD-92C1-4E4A-9977-7AE15FB53026Q27013018-44CD1362-94DA-483A-BA1F-794B46C81C8EQ27646563-86E78933-288A-425A-A10E-0AD4A29EF2FDQ27676892-9604F70A-D482-496D-A5EC-81FC82B82B4DQ28066101-CF570C45-6027-41C9-9655-1811CDE1E51CQ28072683-7F70B5AF-FE28-4F1C-803E-9E3F869E3679Q28830058-21000ADD-99F8-4C19-B18E-7BE08A4159ACQ30250366-6BEB8308-FFE0-4887-A910-1199A4373847Q30366046-04DBE4C4-B3DA-41F8-8EB4-ABA6D690F8F5Q30375781-2991E66F-426A-44A8-B5E8-356F97E41EF4Q33429348-E99AD5B8-8815-4678-AFCC-1B973CE58076Q33636884-D52C91E1-56E3-4E5C-BC9A-F3FE1D485638Q33812653-88FD02E1-3587-4771-A658-8BB866D74565Q34166393-D2C672CF-0799-4B1D-BA7F-4B29FFF0CF5CQ34236742-1F2EA878-5AEA-4179-B102-5D2AE2576CFCQ34479052-F2F45CAC-ACBC-4E73-94E8-5E6160B1C01AQ34485189-74C3A86B-AF2C-4E83-A859-80A0DFB710D4Q34497852-C1C9BF8E-3C2C-4EC6-82F6-9A16EBCD7E05Q34539563-C1B85004-D33E-416D-AE73-FCEF0C69D14FQ34871606-DFC89D3F-7889-4DCB-B1B4-AF870CA5B27BQ35806627-062F5120-C0D7-4C3C-A234-F2F2E0C127A7Q35961324-ECC1D30A-BE66-46E2-B921-048B02C75515Q36099367-1F1485A4-4ACD-421E-B0FD-250CD0EFC81EQ36103394-05C8A2DB-5FE5-4807-8322-AD4BBD77B394Q36245120-8181EEAC-5F0A-4DEB-91CB-F86ACD4F1D5BQ36553413-506BE7AF-6C45-42E4-8D63-EBE216DFBDD9Q36610885-33EA502F-4FA6-4521-BCE9-C46424522C0FQ36640766-FE502770-A725-47B3-BDB6-F64F80D4596FQ36827268-F6C3404E-DF59-46F5-B81B-B4AEF9547343Q36973372-8AE25636-3B9D-4D38-A2A4-3B7FD3BC6CB6Q37374797-F8CE664F-6F87-4D75-B71E-96A5F0F2AE15Q37589024-402202D5-DC0F-4DA0-B330-C2E2448EE4BCQ37792984-88861AE1-186D-457E-990E-94988D91AE01Q37821590-86DCDCCA-7DE6-41EE-9E74-530387B3F724Q38014371-071E63FD-5C32-410E-88C6-3C97C0712C52Q38396830-0220F8DB-B396-45D8-B974-AA20E3A685D9Q38618258-6FCE78C7-2BF5-42FC-95D9-93EC2CF40A5CQ38772626-9D682768-B677-490D-A3AD-3A088EBEB6AEQ38930099-0EB81947-026E-48E2-A0BA-37A91607E2A4Q38950048-F121C85D-FFF6-4E54-9BB7-32478C1D129F
P2860
Essential elements of the capsid protein for self-assembly into empty virus-like particles of hepatitis E virus.
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Essential elements of the caps ...... articles of hepatitis E virus.
@ast
Essential elements of the caps ...... articles of hepatitis E virus.
@en
Essential elements of the caps ...... articles of hepatitis E virus.
@nl
type
label
Essential elements of the caps ...... articles of hepatitis E virus.
@ast
Essential elements of the caps ...... articles of hepatitis E virus.
@en
Essential elements of the caps ...... articles of hepatitis E virus.
@nl
prefLabel
Essential elements of the caps ...... articles of hepatitis E virus.
@ast
Essential elements of the caps ...... articles of hepatitis E virus.
@en
Essential elements of the caps ...... articles of hepatitis E virus.
@nl
P2093
P2860
P1433
P1476
Essential elements of the caps ...... articles of hepatitis E virus.
@en
P2093
Helena Engvall
Joseph C Y Wang
Lena Hammar
Naokazu Takeda
R Holland Cheng
Tatsuo Miyamura
Tian-Cheng Li
P2860
P304
12999-13006
P356
10.1128/JVI.79.20.12999-13006.2005
P407
P577
2005-10-01T00:00:00Z